Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3227441000168110 | chondroitin sulfate sodium 40 mg / 1 mL + hyaluronate sodium 30 mg / 1 mL intraocular injection, 1 x 0.5 mL syringe (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3227451000168112 | chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | Is a | medicinal product pack | false | Inferred relationship | Some | ||
| chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | has MPUU | chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Viscoat intraocular injection, 0.5 mL syringe | Is a | False | chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set